{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01583",
      "entity_text" : "IL-1alpha",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01590",
      "entity_text" : "Hypoxic factors",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Hypoxic factors are targeted in cancer therapy to use hypoxia mediated cell death to kill cancerous cells; therefore, it is important to take into consideration that while pro angiogenic factors, such as VEGF will be down-regulated, this treatment may either up- or down-regulate IL-1alpha, depending on the cell type.",
  "reading_complete" : "2020-08-04T10:36:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T10:35:19Z",
  "trigger" : "down-regulate",
  "evidence" : [ "Hypoxic factors are targeted in cancer therapy to use hypoxia-mediated cell death to kill cancerous cells; therefore, it is important to take into consideration that while pro-angiogenic factors, such as VEGF will be down-regulated, this treatment may either up- or down-regulate IL-1alpha" ],
  "pmc_id" : "3442192",
  "score" : 0
}